These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 25000385)

  • 1. Magnetically guided recellularization of decellularized stented porcine pericardium-derived aortic valve for TAVI.
    Ghodsizad A; Bordel V; Wiedensohler H; Elbanayosy A; Koerner MM; Gonzalez Berjon JM; Barrios R; Farag M; Zeriouh M; Loebe M; Noon GP; Koegler G; Karck M; Ruhparwar A
    ASAIO J; 2014; 60(5):582-6. PubMed ID: 25000385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells.
    Fang NT; Xie SZ; Wang SM; Gao HY; Wu CG; Pan LF
    Chin Med J (Engl); 2007 Apr; 120(8):696-702. PubMed ID: 17517187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete Static Repopulation of Decellularized Porcine Tissues for Heart Valve Engineering: An in vitro Study.
    Roosens A; Asadian M; De Geyter N; Somers P; Cornelissen R
    Cells Tissues Organs; 2017; 204(5-6):270-282. PubMed ID: 29131080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue engineering of cardiac valves: re-seeding of acellular porcine aortic valve matrices with human mesenchymal progenitor cells.
    Knight RL; Booth C; Wilcox HE; Fisher J; Ingham E
    J Heart Valve Dis; 2005 Nov; 14(6):806-13. PubMed ID: 16359063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is Transcatheter Aortic Valve Implantation of Living Tissue-Engineered Valves Feasible? An In Vitro Evaluation Utilizing a Decellularized and Reseeded Biohybrid Valve.
    Koenig F; Lee JS; Akra B; Hollweck T; Wintermantel E; Hagl C; Thierfelder N
    Artif Organs; 2016 Aug; 40(8):727-37. PubMed ID: 27187768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue engineering of functional trileaflet heart valves from human marrow stromal cells.
    Hoerstrup SP; Kadner A; Melnitchouk S; Trojan A; Eid K; Tracy J; Sodian R; Visjager JF; Kolb SA; Grunenfelder J; Zund G; Turina MI
    Circulation; 2002 Sep; 106(12 Suppl 1):I143-50. PubMed ID: 12354724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biocompatibility and recellularization potential of an acellular porcine heart valve matrix.
    Wilcox HE; Korossis SA; Booth C; Watterson KG; Kearney JN; Fisher J; Ingham E
    J Heart Valve Dis; 2005 Mar; 14(2):228-36; discussion 236-7. PubMed ID: 15792184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow-dependent re-endothelialization of tissue-engineered heart valves.
    Lichtenberg A; Cebotari S; Tudorache I; Sturz G; Winterhalter M; Hilfiker A; Haverich A
    J Heart Valve Dis; 2006 Mar; 15(2):287-93; discussion 293-4. PubMed ID: 16607913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aortic valve cell seeding into decellularized animal pericardium by perfusion-assisted bioreactor.
    Amadeo F; Boschetti F; Polvani G; Banfi C; Pesce M; Santoro R
    J Tissue Eng Regen Med; 2018 Jun; 12(6):1481-1493. PubMed ID: 29702745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro generation of atrioventricular heart valve neoscaffolds.
    Weymann A; Radovits T; Schmack B; Li S; Korkmaz S; Soós P; Istók R; Veres G; Chaimow N; Karck M; Szabó G
    Artif Organs; 2014 Jul; 38(7):E118-28. PubMed ID: 24842040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multifunctional bioreactor for three-dimensional cell (co)-culture.
    Lichtenberg A; Dumlu G; Walles T; Maringka M; Ringes-Lichtenberg S; Ruhparwar A; Mertsching H; Haverich A
    Biomaterials; 2005 Feb; 26(5):555-62. PubMed ID: 15276363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete dynamic repopulation of decellularized heart valves by application of defined physical signals-an in vitro study.
    Schenke-Layland K; Opitz F; Gross M; Döring C; Halbhuber KJ; Schirrmeister F; Wahlers T; Stock UA
    Cardiovasc Res; 2003 Dec; 60(3):497-509. PubMed ID: 14659795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue engineering of heart valves by recellularization of glutaraldehyde-fixed porcine valves using bone marrow-derived cells.
    Kim SS; Lim SH; Cho SW; Gwak SJ; Hong YS; Chang BC; Park MH; Song KW; Choi CY; Kim BS
    Exp Mol Med; 2006 Jun; 38(3):273-83. PubMed ID: 16819286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo autologous recellularization of a tissue-engineered heart valve: are bone marrow mesenchymal stem cells the best candidates?
    Vincentelli A; Wautot F; Juthier F; Fouquet O; Corseaux D; Marechaux S; Le Tourneau T; Fabre O; Susen S; Van Belle E; Mouquet F; Decoene C; Prat A; Jude B
    J Thorac Cardiovasc Surg; 2007 Aug; 134(2):424-32. PubMed ID: 17662783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The decellularized porcine heart valve matrix in tissue engineering: platelet adhesion and activation.
    Kasimir MT; Weigel G; Sharma J; Rieder E; Seebacher G; Wolner E; Simon P
    Thromb Haemost; 2005 Sep; 94(3):562-7. PubMed ID: 16268473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cell-based tissue engineering of small-diameter blood vessels.
    Dong JD; Huang JH; Gao F; Zhu ZH; Zhang J
    Vascular; 2011 Aug; 19(4):206-13. PubMed ID: 21784877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue engineering of heart valves: biomechanical and morphological properties of decellularized heart valves.
    Tudorache I; Cebotari S; Sturz G; Kirsch L; Hurschler C; Hilfiker A; Haverich A; Lichtenberg A
    J Heart Valve Dis; 2007 Sep; 16(5):567-73; discussion 574. PubMed ID: 17944130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue engineering of heart valves: decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells.
    Rieder E; Seebacher G; Kasimir MT; Eichmair E; Winter B; Dekan B; Wolner E; Simon P; Weigel G
    Circulation; 2005 May; 111(21):2792-7. PubMed ID: 15911701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vitro development of autologous fibrin-based tissue-engineered heart valves through optimised dynamic conditioning.
    Flanagan TC; Cornelissen C; Koch S; Tschoeke B; Sachweh JS; Schmitz-Rode T; Jockenhoevel S
    Biomaterials; 2007 Aug; 28(23):3388-97. PubMed ID: 17467792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of tissue-engineered aortic valves.
    Zeltinger J; Landeen LK; Alexander HG; Kidd ID; Sibanda B
    Tissue Eng; 2001 Feb; 7(1):9-22. PubMed ID: 11224920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.